---
title: "RX PHARMATECH LTD — Ownership Dossier"
canonical: https://whiteintel.dev/entity/ef2aa537-17a3-5aef-ba8f-69ed27debfe7
json: https://whiteintel.dev/api/public/dossier/ef2aa537-17a3-5aef-ba8f-69ed27debfe7
identifier: oo:GB-COH-10206961
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# RX PHARMATECH LTD

**Type:** Company  
**Jurisdiction:** GB  
**Identifier:** `oo:GB-COH-10206961`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/ef2aa537-17a3-5aef-ba8f-69ed27debfe7  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/ef2aa537-17a3-5aef-ba8f-69ed27debfe7  

## Ownership & control

### Owners / controllers

- **Mr Dominic James Bartle** (beneficial owner) — 50% — https://whiteintel.dev/entity/22aba1f2-7d1b-5e5c-8283-4c133e62b707
- **Mr Damien Jonathan Bove** (beneficial owner) — 50% — https://whiteintel.dev/entity/c00bf0e0-7009-5b7d-be80-d368660c72fe
- **RX PHARMATECH LTD** (beneficial owner) — 100% — https://whiteintel.dev/entity/ef2aa537-17a3-5aef-ba8f-69ed27debfe7
- **Mr Dominic James Bartle** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/6051fff9-6be2-4a34-a2e1-6e5cf37e646b
- **Mr Damien Jonathan Bove** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/cf5c5c43-05b4-40b0-8e32-44867d975b6a
- **Gvbiopharma (Uk) Ltd** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/3190da22-3f94-464a-8e4a-1609e5867981

### UBO chain (walk to the ultimate owner)

1. **Mr Dominic James Bartle** — beneficial owner 50% → *RX PHARMATECH LTD*
1. **Mr Damien Jonathan Bove** — beneficial owner 50% → *RX PHARMATECH LTD*
1. **RX PHARMATECH LTD** — beneficial owner 100% → *RX PHARMATECH LTD*
1. **Mr Dominic James Bartle** — beneficial owner 37.5% → *RX PHARMATECH LTD*
1. **Mr Damien Jonathan Bove** — beneficial owner 37.5% → *RX PHARMATECH LTD*
1. **Gvbiopharma (Uk) Ltd** — beneficial owner 87.5% → *RX PHARMATECH LTD*

## Company profile (live · UK Companies House)

- **Company number:** `10206961`
- **Status:** liquidation
- **Type:** ltd
- **Incorporated:** 2016-05-31
- **Registered office:** 6 Festival Building, Ashley Lane, Saltaire, BD17 7DQ
- **SIC:** 46900

### Officers

- MULDOWNEY, Karl — director · Irish · appointed 2023-01-19
- HUTCHINSON, Jacqui Sonia — secretary · appointed 2018-05-08 · resigned 2018-09-13
- BARTLE, Dominic James — director · English · appointed 2017-09-01 · resigned 2023-01-19
- BOVE, Damien Jonathan — director · British · appointed 2016-05-31 · resigned 2023-01-19
- PRZYBYLA, Steven Paul — director · American · appointed 2023-01-19 · resigned 2025-05-12

### Beneficial owners (Persons with Significant Control)

- Gvbiopharma (Uk) Ltd — 75–100% shares · corporate PSC · England — since 2023-01-19
- Mr Dominic James Bartle — 25–50% shares · individual PSC · United Kingdom — ceased 2023-01-19
- Mr Damien Jonathan Bove — 25–50% shares · individual PSC · United Kingdom — ceased 2023-01-19

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/10206961
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/10206961

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **RX PHARMATECH LTD**. Human view: https://whiteintel.dev/entity/ef2aa537-17a3-5aef-ba8f-69ed27debfe7 · Structured JSON: https://whiteintel.dev/api/public/dossier/ef2aa537-17a3-5aef-ba8f-69ed27debfe7._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._